InvestorsHub Logo
Followers 2
Posts 52
Boards Moderated 0
Alias Born 09/22/2008

Re: None

Thursday, 11/05/2015 9:57:22 AM

Thursday, November 05, 2015 9:57:22 AM

Post# of 2888
Quote from the letter: "Revenues derived from our cell lines increased by 67% during 2015 as compared to 2014. Also, sales of our cell culture media expanded by 100% in 2015 compared to 2014 due to increased demand for our research products"

It does note later that overall YOY revenues decreased 30% due largely to European conditions. However the focus on TBI treatments and the items mentioned above are likely the keys to seeing overall increased revenues in 2016.

I firmly believe that with the capital structure being what it is the focus in the TBI area will push this stock to previously unseen levels.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.